539 related articles for article (PubMed ID: 24857380)
1. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
[TBL] [Abstract][Full Text] [Related]
2. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
3. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
[TBL] [Abstract][Full Text] [Related]
4. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
5. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
6. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
7. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N
Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545
[TBL] [Abstract][Full Text] [Related]
8. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma.
Hwang ES; Nyante SJ; Yi Chen Y; Moore D; DeVries S; Korkola JE; Esserman LJ; Waldman FM
Cancer; 2004 Jun; 100(12):2562-72. PubMed ID: 15197797
[TBL] [Abstract][Full Text] [Related]
9. Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?
Sadek BT; Shenouda MN; Abi Raad RF; Niemierko A; Keruakous AR; Goldberg SI; Taghian AG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):726-30. PubMed ID: 24064317
[TBL] [Abstract][Full Text] [Related]
10. Is there a low-grade precursor pathway in breast cancer?
King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
[TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma in situ: observation without surgery as an appropriate therapy.
Carson W; Sanchez-Forgach E; Stomper P; Penetrante R; Tsangaris TN; Edge SB
Ann Surg Oncol; 1994 Mar; 1(2):141-6. PubMed ID: 7834439
[TBL] [Abstract][Full Text] [Related]
12. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status.
Stolier AJ; Barre G; Bolton JS; Fuhrman GM; Looney S
Am Surg; 2004 Sep; 70(9):818-21. PubMed ID: 15481302
[TBL] [Abstract][Full Text] [Related]
13. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ
Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.
Nayar R; Zhuang Z; Merino MJ; Silverberg SG
Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790
[TBL] [Abstract][Full Text] [Related]
15. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy.
Abner AL; Connolly JL; Recht A; Bornstein B; Nixon A; Hetelekidis S; Silver B; Harris JR; Schnitt SJ
Cancer; 2000 Mar; 88(5):1072-7. PubMed ID: 10699897
[TBL] [Abstract][Full Text] [Related]
16. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
17. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
Elsheikh TM; Silverman JF
Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
[TBL] [Abstract][Full Text] [Related]
18. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?
Cutuli B; de Lafontan B; Quetin P; Mery E
Eur J Cancer; 2005 Feb; 41(3):380-5. PubMed ID: 15691636
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.
Andrade VP; Morrogh M; Qin LX; Olvera N; Giri D; Muhsen S; Sakr RA; Schizas M; Ng CK; Arroyo CD; Brogi E; Viale A; Morrow M; Reis-Filho JS; King TA
Mol Oncol; 2015 Apr; 9(4):772-82. PubMed ID: 25601220
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for women with lobular carcinoma in situ (LCIS).
Oppong BA; King TA
Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
